Article Details
Retrieved on: 2024-02-26 18:06:29
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the growth of the biopharmaceutical market for follicular lymphoma, covering the anticipated market expansion due to new diagnostic methods and treatments. It highlights key companies like AbbVie, Seagen, Genmab, and therapies like CAR T-cell therapy and emerging drugs in countries including the US and Japan.
Article found on: www.investorsobserver.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here